Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04595422 · ClinicalTrials.gov registry record · NA

Educating Smokers About Lung Cancer Screening Using Tobacco Quitlines

A NA study of Lung Carcinoma, sponsored by M.D. Anderson Cancer Center.

Recruiting
Registry status
NA
Development phase
800
Enrollment target
1
Study location

NCT04595422: Recruiting NA study of Lung Carcinoma, sponsored by M.D. Anderson Cancer Center.

NCT04595422 is a NA study of Lung Carcinoma that is actively recruiting participants, run by M.D. Anderson Cancer Center. The registered enrollment target is 800 participants, below the 5,023-participant average among 38 other Lung Carcinoma trials with a reported enrollment target (84% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04595422, a NA study of Lung Carcinoma, is actively recruiting participants, sponsored by M.D. Anderson Cancer Center.

RECRUITING
Registry status
NA
Development phase
800 participants
Enrollment target
1
Study location

Study Summary

This implementation study will examine the best ways to refer heavy smokers to information about lung cancer screening.

Conditions Studied

Interventions

  • OTHER Survey Administration
  • OTHER Questionnaire Administration
  • OTHER Educational Intervention

Study Locations (1)

Texas

  • M D Anderson Cancer Center - Houston

Trial Details

FieldValue
Enrollment Target 800 participants
Start Date 2020-07-02
Est. Completion 2026-10-31
Phase NA

Sponsor

M.D. Anderson Cancer Center

2,692 total trials

What the Registry Record Tells You About NCT04595422

The ClinicalTrials.gov registry entry for NCT04595422 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 800 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 5,023-participant average among 38 other Lung Carcinoma trials with a reported enrollment target (84% lower). The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Lung Carcinoma appearing as the primary indexed condition, and to 3 interventions - of which Survey Administration is the first listed.

NCT04595422 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT04595422 about?

NCT04595422 is a clinical study titled "Educating Smokers About Lung Cancer Screening Using Tobacco Quitlines". This implementation study will examine the best ways to refer heavy smokers to information about lung cancer screening.

What is the current status of trial NCT04595422?

This trial is currently recruiting. It is a NA study. The enrollment target is 800 participants. The study started on 2020-07-02. Estimated completion is 2026-10-31.

What conditions does trial NCT04595422 study?

This clinical trial studies the following conditions: Lung Carcinoma.

What interventions are being tested in trial NCT04595422?

The interventions under investigation include: Survey Administration (OTHER), Questionnaire Administration (OTHER), Educational Intervention (OTHER).

Who is sponsoring clinical trial NCT04595422?

This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04595422 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Lung Carcinoma

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.